Spyre Therapeutics, Inc.

BANK OF AMERICA CORP /DE/ SYRE

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

35,230

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	10	0.0%	35,230	3/31/2023
2022 Q4	2/10/2023	7	0.0%	15,770	12/31/2022
2022 Q3	11/14/2022	6	0.0%	11,676	9/30/2022
2022 Q2	8/12/2022	4	0.0%	7,301	6/30/2022
2022 Q1	5/16/2022	41	0.0%	18,005	3/31/2022
2021 Q4	2/8/2022	147	0.0%	31,067	12/31/2021
2021 Q3	11/15/2021	204	0.0%	25,639	9/30/2021
2021 Q2	9/13/2021	141	0.0%	20,216	6/30/2021
2021 Q1	5/14/2021	314	0.0%	39,690	3/31/2021
2020 Q4	2/10/2021	106	0.0%	13,517	12/31/2020
2020 Q3	11/13/2020	351	0.0%	49,490	9/30/2020
2020 Q2	8/14/2020	179	0.0%	19,337	6/30/2020
2020 Q1	5/15/2020	63	0.0%	13,430	3/31/2020
2019 Q4	2/14/2020	191	0.0%	25,041	12/31/2019